| Dr Seyed Nematolah Moussavian, MD | |
|
9200 Montgomery Rd, Cincinnati, OH 45242-7789 | |
| (513) 891-1240 | |
| (513) 891-3561 |
| Full Name | Dr Seyed Nematolah Moussavian |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 9200 Montgomery Rd, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285772582 | NPI | - | NPPES |
| 0377211 | Medicaid | OH |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Seyed Nematolah Moussavian, MD 9200 Montgomery Rd, Cincinnati, OH 45242-7789 Ph: (513) 891-1240 | Dr Seyed Nematolah Moussavian, MD 9200 Montgomery Rd, Cincinnati, OH 45242-7789 Ph: (513) 891-1240 |
News Archive
Two months after the opening of the CDH Proton Center, A ProCure Center, the first patients have "graduated" from their treatment surrounded by family, friends and staff. The group of graduating patients, whose tumors included prostate, brain and a non-cancerous tumor on the spinal cord, received proton therapy, an alternative to standard X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
The Penn Transplant Institute, the Department of Orthopaedic Surgery and the Division of Plastic Surgery at the Hospital of the University of Pennsylvania (HUP) have collaborated to form the Penn Hand Transplant Program.
Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.
Scientists at the University of Liverpool have developed a therapy programme to treat depression in women in developing countries.
A new study from Mayo Clinic finds the use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, an acute inflammation of the liver caused by excessive consumption of alcohol. The results of the study are published in the December issue of Gastroenterology.
› Verified 3 days ago
Smith Bearelly, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10500 Montgomery Rd, Cincinnati, OH 45242 Phone: 513-865-2246 Fax: 513-865-5596 | |
Dr. Caitlin Ann Richter, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Ml0781, Cincinnati, OH 45219 Phone: 513-584-4505 Fax: 513-584-0468 | |
Muhammad Yaseen, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 375 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-862-3306 Fax: 513-862-3421 | |
Sandra E Dickens, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 375 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-872-3452 Fax: 513-872-3421 | |
Juan Carlos Mejia, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 375 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-862-3452 Fax: 513-862-3421 | |
Amanda Schondelmeyer, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 3333 Burnet Ave, Ml 3016, Cincinnati, OH 45229 Phone: 513-636-4588 Fax: 513-636-0345 | |
Dr. Juan Fernando Martinez, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-475-8000 |